ARTICLE | Company News
Lubris, Novartis deal
April 14, 2017 7:41 PM UTC
Novartis exercised an option for exclusive, ex-European rights to ECF843 recombinant human lubricin from Lubris for ophthalmic indications. The candidate has completed a Phase II trial in dry eye. The partners declined to disclose financial terms. ...
BCIQ Target Profiles